Abiraterone Acetate Self-Emulsifying Composition for Oral Bioavailability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Abiraterone acetate has low solubility and poor permeability, leading to low oral bioavailability and significant variability in absorption due to food intake, necessitating specific administration times and complicating formulation design.
Innovation Solution
A pharmaceutical composition comprising abiraterone acetate with specific excipients that form a self-emulsifying solution, spontaneously forming an O/W nanoemulsion upon gastrointestinal contact, enhancing absorption and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If abiraterone acetate is administered orally in conventional tablet form, then the drug can be delivered to the gastrointestinal tract, but the oral bioavailability is extremely low (less than 10%) due to poor solubility and permeability
Solution Approach 1:
The patent uses self-emulsifying excipients as intermediary substances that facilitate the dissolution and absorption of abiraterone acetate. These excipients act as mediators between the lipophilic drug and the aqueous gastrointestinal environment, forming emulsions that enhance bioavailability without requiring complex formulation modifications.
Solution Approach 2:
The patent changes the physical and chemical parameters of the drug delivery system by incorporating self-emulsifying excipients that alter the solubility and permeability characteristics of abiraterone acetate. This parameter change enables the drug to transition from a poorly absorbed state to a highly bioavailable state, achieving several-fold increase in oral bioavailability.
2Reliability
If abiraterone acetate is taken with food, then the absorption may be enhanced, but the plasma concentration becomes highly variable and unpredictable
Solution Approach 1:
The self-emulsifying formulation system serves itself by automatically forming emulsions in the gastrointestinal tract regardless of food intake status. The excipients self-assemble around the drug molecules, creating a consistent absorption mechanism that does not depend on external factors like food, thereby eliminating plasma concentration variability while maintaining administration flexibility.
3Reliability
If the dose of abiraterone acetate is increased to improve efficacy, then the treatment effectiveness increases, but the low bioavailability means that only a small fraction of the dose is actually absorbed
Solution Approach 1:
The patent changes the absorption parameters of abiraterone acetate by incorporating self-emulsifying excipients, which fundamentally alters how the drug is processed in the gastrointestinal tract. This parameter change enables significantly higher absorption rates, meaning that at the same administered dose, much more drug reaches the systemic circulation, thereby improving treatment efficacy without requiring excessive dose increases.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition significantly increases oral bioavailability by several to ten times, reduces meal-related variability, and allows administration under both empty-stomach and full-stomach conditions, improving treatment efficacy for prostate cancer.
Implementation Method 1
A pharmaceutical composition comprising abiraterone acetate with specific excipients that form a self-emulsifying solution, spontaneously forming an O/W nanoemulsion upon gastrointestinal contact
Implementation Method 2
spontaneously forming an O/W nanoemulsion upon gastrointestinal contact, enhancing absorption and stability
Data Source
AI summary
A drug composition containing abiraterone acetate, and a preparation method therefor and an application thereof. Excipients thereof comprise at least one oil phase, at least one emulsifier, and at least one co-emulsifier. The dug composition can obviously improve the bioavailability and the stability of a preparation. The drug composition can be further prepared as capsules.